Fang Wu

Dr. Fang Wu

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 August 2025 in BMC Cancer
Verified
Journal Article
Open access
PDF file
JQJia-Ning Qin
Jia-Ning Qin
WDWen-Bin Dai
Wen-Bin Dai
WZWen-Hai Zhang
Wen-Hai Zhang
BCBin-Jie Chen
Bin-Jie Chen
LLLing Liang
Ling Liang
FWFang Wu
Fang Wu
The aim of this study was to identify optimal biomarkers associated with distant metastasis in patients with breast cancer from among nutritional and inflammatory indicators using the Boruta and Least Absolute Shrinkage and Selection Operator (LASSO) machine learning algorithms, thereby improving the ability to identify distant metastasis. A total of 348 patients newly diagnosed with breast cancer were included, comprising 185 patients with nonmetastatic breast cancer and 163 patients with distant metastatic breast cancer. The variables were initially screened using the Boruta algorithm, followed by further optimization through LASSO regression. The selected key indicators were evaluated for their association with distant metastasis risk using multivariate logistic regression analysis and restricted cubic spline functions. Discriminative performance was assessed through ROC curve analysis. Boruta and LASSO analyses identified five important indicators: the advanced lung cancer inflammation index (ALI), systemic inflammation response index (SIRI), monocyte-to-lymphocyte ratio (MLR), albumin-to-globulin ratio (AGR), and geriatric nutritional risk index (GNRI). Multivariate logistic regression analysis revealed that an elevated SIRI and MLR were associated with an increased risk of distant metastasis in patients with breast cancer, whereas a higher ALI, AGR, and GNRI were associated with a reduced risk. ROC analysis indicated moderate predictive performance for these indicators, with AUC values of approximately 0.65. The ALI, SIRI, MLR, AGR, and GNRI are effective biomarkers for identifying the risk of distant metastasis in patients with breast cancer. These indicators could be incorporated into clinical practice to improve risk stratification, guide personalized treatment, and enhance patient outcomes.

25 April 2024 in Frontiers in Oncology
Verified
Journal Article
Open access
PDF file
TGTing Gao
Ting Gao
ZYZixuan Yang
Zixuan Yang
LWLiqun Wei
Liqun Wei
XTXiaobi Tang
Xiaobi Tang
SMShanshan Ma
Shanshan Ma
FWFang Wu
Fang Wu
Background: Stage IIIC1p cervical cancer is characterized by marked heterogeneity and considerable variability in the postoperative prognosis. This study aimed to identify the clinical and pathological characteristics affecting the survival of patients diagnosed with stage IIIC1p cervical cancer.Methods: We retrospectively analyzed patients diagnosed with stage IIIC1p cervical cancer who underwent radical hysterectomy and lymph node dissection between March 2012 and March 2022. Overall survival (OS) was estimated using Kaplan-Meier survival curves. Univariate and multivariate Cox proportional hazards models were used to evaluate prognostic factors for OS and forest plots were used to visualize these findings. Nomogram charts were created to forecast survival rates at 3 and 5 years, and the accuracy of predictions was evaluated using Harrell’s concordance index (C-index) and calibration curves.Results: The study cohort comprised 186 women diagnosed with stage IIIC1p cervical cancer. The median follow-up duration was 51.1 months (range, 30-91 months), and the estimated 5-year OS rate was 71.5%. Multivariate analysis revealed that concurrent chemoradiotherapy plus adjuvant chemotherapy (CCRT + AC), monocyte-lymphocyte ratio (MLR), ratio of lymph node metastasis (LNM), and squamous cell carcinoma antigen (SCCA) levels independently predicted OS.Conclusions: Significant prognostic disparities exist among patients diagnosed with stage IIIC1p cervical cancer. MLR, ratio of LNM, and SCCA were associated with poor OS. In contrast, the CCRT + AC treatment regimen appeared to confer a survival advantage.

5 September 2023 in Apoptosis
Verified
Journal Article
Closed access
PDF file
CZCheng-Shan Zheng
Cheng-Shan Zheng
WHWei-Mei Huang
Wei-Mei Huang
HXHong-Mei Xia
Hong-Mei Xia
JMJing-Lin Mi
Jing-Lin Mi
YLYuan-Qing Li
Yuan-Qing Li
FWFang Wu
Fang Wu

1 January 2024 in Technology in Cancer Research & Treatment
Verified
Journal Article
Open access
TGTing Gao
Ting Gao
LWLiqun Wei
Liqun Wei
LJLi Jiang
Li Jiang
SMShanshan Ma
Shanshan Ma
WZWei Zhang
Wei Zhang
FWFang Wu
Fang Wu
Background: The objective of this investigation is to evaluate the superiority of dose-volume parameters relying on magnetic resonance imaging (MRI)-defined active bone marrow (ABM) over those based on total bone marrow (TBM) contoured via CT in the prediction of hematologic toxicity (HT) occurrence among patients with pelvic malignancies undergoing radiotherapy. Methods: The clinical data of 116 patients with pelvic malignancies treated with pelvic radiotherapy were analyzed retrospectively. The ABM areas on T1-weighted MRI were contoured. The statistical significance between TBM and ABM dose-volume measures was assessed through the utilization of either Student’s t-test or Wilcoxon signed rank test. Logistic and linear regression models were employed to analyze the correlation between dose-volume parameters (V5-V50) and HT occurrence in pelvic ABM and TBM. Receiver operating characteristic (ROC) curves were used to compare predictors of HT2+. Results: There were significant differences in dosimetric parameters between ABM and TBM. Logistic regression analysis showed that ABM V5, ABM V10, ABM V15, ABM V20, and TBM V5 were significantly associated with the occurrence of HT2+ in pelvic malignancies. Linear regression analysis showed that ABM V5, ABM V10, and ABM V15 were significantly associated with white blood cell (WBC), absolute neutrophil count (ANC), hemoglobin (Hb), and lymphocyte (Lym) nadir. ABM V5, ABM V10, ABM V15, and ABM V30 were predictive of HT2+. Conclusions: More accurate prediction of HT in patients receiving pelvic radiotherapy may be achieved by relying on dose-volume parameters of MRI-based ABM. Further prospective studies are needed to confirm this.

30 August 2024 in Discover Oncology
Verified
Journal Article
Open access
PDF file
JFJiangping Fu
Jiangping Fu
YCYaohua Chen
Yaohua Chen
JLJie Li
Jie Li
MTming tan
ming tan
RLRui Lin
Rui Lin
FWFang Wu
Fang Wu
Background Non-small cell lung cancer (NSCLC) is the most common type of tumor globally and the leading cause of cancer-related deaths. Although treatment strategies such as immune checkpoint inhibitors and chemotherapy have advanced, the heterogeneity among NSCLC patients results in significant variability in treatment outcomes. Studies have shown that certain patients respond poorly to immune checkpoint inhibitors, indicating that treatment response is closely related to multiple factors. Therefore, it is necessary to develop predictive models to stratify patients based on gene expression and clinical characteristics, aiming for precision therapy. Objective This study aims to construct a stratified prognostic model for NSCLC patients based on lysosome-dependent cell death (LDCD) scoring by integrating single-cell RNA sequencing (scRNA-seq) and bulk RNA sequencing data. By analyzing the immune-related characteristics of high-risk and low-risk groups, we further explored the impact of cell death patterns on lung cancer and identified potential therapeutic targets. Methods This study obtained single-cell RNA sequencing data and gene expression data of NSCLC patients and normal lung tissues from the GEO and TCGA databases. We used R packages such as Seurat and CellChat for data preprocessing and analysis, and performed dimensionality reduction and visualization through Principal Component Analysis (PCA) and UMAP algorithms. LASSO regression analysis was used to construct the predictive model, followed by cross-validation and ROC curve analysis. The model’s effectiveness was validated through survival analysis and immune microenvironment analysis. Results The study showed a significant increase in the proportion of monocytes in NSCLC tissues, suggesting their important role in cancer progression. Cell communication analysis indicated that macrophages, smooth muscle cells, and myeloid cells exhibit strong intercellular communication during cancer progression. Using the constructed prognostic model based on 12 LDCD-related genes, we found significant differences in overall survival and immune microenvironment between the high-risk and low-risk groups.

16 December 2024 in Cancer Medicine
Verified
Journal Article
Open access
TWTinglu Wang
Tinglu Wang
JWJinchen Wei
Jinchen Wei
LJLi Jiang
Li Jiang
LHLulu Huang
Lulu Huang
THTingting Huang
Tingting Huang
FWFang Wu
Fang Wu
Background and Purpose: The indications of prophylactic extended‐field radiotherapy (EFRT) remain uncertain. This study aims to identify the risk factors for para‐aortic lymph node (PALN) metastases in locally advanced cervical cancer (LACC) and determine which part of patients may benefit from prophylactic EFRT.Materials and Methods: Between January 2015 and July 2023, a single‐center retrospective analysis was performed on patients with stages IB3 and IIA2‐IVA cervical cancer. Lymph node involvement was assessed using positron emission tomography/computed tomography (PET/CT). Risk factors were evaluated by logistic regression. A prediction nomogram model was developed and validated.Results: Among 329 patients, 64 (19.5%) had PALN metastases. Univariate analysis indicated that tumor size > 5.3 cm, tumor maximum standardized uptake value (SUVmax) > 9.8, bilateral pelvic lymph node (PLN) metastases, the number of positive PLNs ≥ 3, and T3–T4 stages were related to PALN metastases. After multivariate logistic analysis, it was found that tumor size > 5.3 cm (odds ratio [OR] = 3.129, 95% confidence interval [CI] = 1.536–6.374, p = 0.002), and the number of positive PLNs ≥ 3 (OR = 11.260, 95% CI = 3.506–36.158, p < 0.001) were independent risk factors. The C‐index of the nomogram was 0.886 (95% CI = 0.844–0.927). The calibration plot showed that the nomogram was well‐fitted. Decision curve analysis (DCA) exhibited excellent clinical utility.Conclusion: Tumor size > 5.3 cm and the number of positive PLNs ≥ 3 are independent risk factors of PALN metastases. The nomogram shows pretty good accuracy, which may provide a valuable reference for guiding patients who are very likely to develop PALN metastases to receive prophylactic EFRT.